HomeXP0 • FRA
add
Xenon Pharmaceuticals Inc
Previous close
€36.40
Day range
€35.60 - €35.60
Year range
€25.00 - €39.00
Market cap
3.30B USD
Avg Volume
14.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.28M | 15.42% |
Net income | -90.90M | -44.76% |
Net profit margin | — | — |
Earnings per share | -1.15 | -41.98% |
EBITDA | -95.70M | -31.07% |
Effective tax rate | -0.75% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 462.27M | -29.32% |
Total assets | 607.84M | -27.28% |
Total liabilities | 48.32M | 26.86% |
Total equity | 559.51M | — |
Shares outstanding | 77.28M | — |
Price to book | 5.01 | — |
Return on assets | -37.57% | — |
Return on capital | -39.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -90.90M | -44.76% |
Cash from operations | -71.75M | -44.47% |
Cash from investing | 38.53M | 7,637.15% |
Cash from financing | 2.36M | — |
Net change in cash | -30.87M | 37.15% |
Free cash flow | -46.06M | -36.82% |
About
Founded
1996
Headquarters
Website
Employees
322
